CN105727069A - Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition - Google Patents
Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition Download PDFInfo
- Publication number
- CN105727069A CN105727069A CN201610124428.6A CN201610124428A CN105727069A CN 105727069 A CN105727069 A CN 105727069A CN 201610124428 A CN201610124428 A CN 201610124428A CN 105727069 A CN105727069 A CN 105727069A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- fructus
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 61
- 206010008617 Cholecystitis chronic Diseases 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 99
- 239000003814 drug Substances 0.000 claims abstract description 63
- 210000003038 endothelium Anatomy 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 239000008194 pharmaceutical composition Substances 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 30
- 241000628997 Flos Species 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 241000501664 Gentianopsis Species 0.000 claims description 23
- 241000244155 Taenia Species 0.000 claims description 23
- 239000008187 granular material Substances 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 20
- 239000012567 medical material Substances 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 239000005720 sucrose Substances 0.000 claims description 10
- -1 dry Substances 0.000 claims description 9
- 239000000080 wetting agent Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 abstract description 45
- 230000000694 effects Effects 0.000 abstract description 31
- 230000001737 promoting effect Effects 0.000 abstract description 26
- 210000000952 spleen Anatomy 0.000 abstract description 20
- 230000004087 circulation Effects 0.000 abstract description 8
- 210000002216 heart Anatomy 0.000 abstract description 8
- 210000000941 bile Anatomy 0.000 abstract description 6
- 241001289529 Fallopia multiflora Species 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 235000009696 Murraya paniculata Nutrition 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 241000632227 Antenoron Species 0.000 abstract 1
- 235000000832 Ayote Nutrition 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 241000288784 Barleria cristata Species 0.000 abstract 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000014493 Crataegus Nutrition 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 abstract 1
- 240000004244 Cucurbita moschata Species 0.000 abstract 1
- 235000009854 Cucurbita moschata Nutrition 0.000 abstract 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 abstract 1
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 241000025804 Gentianopsis barbata Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000019510 Long pepper Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000261422 Lysimachia clethroides Species 0.000 abstract 1
- 241000721690 Lythrum salicaria Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 241001639335 Mucuna sempervirens Species 0.000 abstract 1
- 240000001899 Murraya exotica Species 0.000 abstract 1
- 235000008766 Murraya exotica Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000005561 Musa balbisiana Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 240000003455 Piper longum Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 235000004789 Rosa xanthina Nutrition 0.000 abstract 1
- 241000109329 Rosa xanthina Species 0.000 abstract 1
- 240000009235 Rubia cordifolia Species 0.000 abstract 1
- 241000124033 Salix Species 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 235000015136 pumpkin Nutrition 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 43
- 230000036407 pain Effects 0.000 description 42
- 210000000232 gallbladder Anatomy 0.000 description 39
- 210000004369 blood Anatomy 0.000 description 36
- 239000008280 blood Substances 0.000 description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 27
- 201000010099 disease Diseases 0.000 description 22
- 230000006870 function Effects 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000001835 viscera Anatomy 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 230000001717 pathogenic effect Effects 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 10
- 210000001015 abdomen Anatomy 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 206010023126 Jaundice Diseases 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 8
- 208000019790 abdominal distention Diseases 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 230000008673 vomiting Effects 0.000 description 7
- 208000000197 Acute Cholecystitis Diseases 0.000 description 6
- 206010008614 Cholecystitis acute Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 201000001883 cholelithiasis Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010003011 Appendicitis Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000001431 Psychomotor Agitation Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000035568 catharsis Effects 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000000994 depressogenic effect Effects 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000005686 eating Nutrition 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 239000008812 xiaoyanlidan Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000002309 gasification Methods 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010062631 Cholecystitis infective Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000037768 Gallbladder perforation Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001662043 Icterus Species 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000029836 Inguinal Hernia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000219991 Lythraceae Species 0.000 description 1
- 241000158728 Meliaceae Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000122904 Mucuna Species 0.000 description 1
- 208000034702 Multiple pregnancies Diseases 0.000 description 1
- 244000188192 Murraya paniculata Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010029379 Neutrophilia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000961970 Plantago depressa Species 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 244000020191 Salix babylonica Species 0.000 description 1
- 235000002493 Salix babylonica Nutrition 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241001058321 Taraxacum sinicum Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- NAHTXVIXCMUDLF-DUJPAFNYSA-N Toosendanin Natural products O=C(O[C@H]1C(=O)[C@H]2[C@@](C)([C@H](O)C[C@H]3[C@@]4(C)[C@H](O)OC[C@@]23[C@@H](O)C[C@H]4OC(=O)C)[C@@]23[C@]1(C)[C@H](c1cocc1)C[C@H]2O3)C NAHTXVIXCMUDLF-DUJPAFNYSA-N 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229930185278 anthraglycoside Natural products 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003591 anti-choleraic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 238000009606 cholecystography Methods 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000026273 gall bladder development Effects 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- JRFKIOFLCXKVOT-UHFFFAOYSA-N hydroxymethylnicotinamide Chemical compound OCNC(=O)C1=CC=CN=C1 JRFKIOFLCXKVOT-UHFFFAOYSA-N 0.000 description 1
- 229950005422 hydroxymethylnicotinamide Drugs 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000005955 light diet Nutrition 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 230000000387 litholytic effect Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- NAHTXVIXCMUDLF-RFNFAWMESA-N toosendanin Chemical compound C=1([C@H]2[C@]3(C)[C@@H](OC(C)=O)C(=O)[C@H]4[C@@]([C@@]53O[C@@H]5C2)(C)[C@H](O)C[C@H]2[C@@]3(C)[C@H](O)OC[C@]24[C@@H](O)C[C@H]3OC(=O)C)C=COC=1 NAHTXVIXCMUDLF-RFNFAWMESA-N 0.000 description 1
- 239000008488 toosendanin Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating chronic cholecystitis. The medicinal composition is prepared from the following raw medicaments: longhairy antenoron herb, officinal magnolia barks, fried gardenia, Szechwan chinaberry fruits, long peppers, roses, endothelium corneum gigeriae galli, bamboo shavings, gentianopsis barbata, oysters, lythrum salicaria, mucuna sempervirens, sanguisorba officinalis, clethra loosestrife herb, pumpkin roots, coix seeds, Philippine violet herb, murraya paniculata, wolfberries, semen cassiae, cowherb seeds, acorus gramineus, rubia cordifolia, cassia twigs, green tangerine peel, hawthorns, licorice, dandelions, hedyotis diffusa, plantain seeds, willow branches, radix polygonum multiflorum preparata and northern divaricate saposhnikovia roots. According to the medicinal composition, the raw medicaments are combined on the basis of the principle of monarch, minister, assistant and guide of traditional Chinese medicine to achieve the effects of clearing liver-gallbladder, soothing the liver, promoting qi circulation, regulating qi activity, clearing away heat and toxic materials, nourishing the heart to tranquilize the mind, invigorating spleen, supplementing qi and promoting bile flow, fulfill the aim of treating chronic cholecystitis and overcome the defects of long treatment course, poor effects and high recurrence rate of modern medicine in treatment of chronic cholecystitis.
Description
Technical field
The invention belongs to pharmaceutical technology field, relate to a kind of Chinese medicine composition, be specifically related to a kind of pharmaceutical composition treating chronic cholecystitis and preparation method thereof.
Background technology
The gallbladder inflammatory lesion that cholecystitis is bacterial infection or chemical irritation (bile component change) causes, for the commonly encountered diseases of gallbladder.In abdominal surgery, its sickness rate is only second to appendicitis, and primary disease is more common in the middle age of 35~55 years old, and the women relatively male that falls ill for many, is more common in the women of obesity and multiple pregnancies especially.
Cholecystitis is divided into chronic cholecystitis and acute cholecystitis two kinds, the normally behaving as variant position pain usually can be made to increase the weight of of acute cholecystitis, and patient likes reposing to the right more, to alleviate abdomen pain, has nausea and vomiting, but vomiting is general inviolent.Great majority are also with heating, and body temperature is generally between 38.0 DEG C~38.5 DEG C, and Gao Re and shiver with cold are actually rare.Minority also has the white of the eye and skin slightly to turn to be yellow.When checking abdominal part, it is possible to find that right upper quadrant of the abdomen has tenderness, and have tension of abdominal muscle, be approximately in the gallbladder that can also touch enlargement in the patient of 1/3.The blood of chemical examination patient, it is found that numeration of leukocyte in most human bloods and neutrophilia.Ultrasound diagnosis can find that gollbladder dilation, cyst wall thicken, and visible calculus gets lodged in the cervical region of gallbladder.According to above symptom, physical examination and various auxiliary examination, doctor generally can make the diagnosis of acute cholecystitis in time.
Chronic cholecystitis is modal a kind of gallbladder disease, and patient generally has cholelithiasis simultaneously, but the chronic cholecystitis patient without calculus sees Chinese quite a few.Chronic cholecystitis can be the sequela of acute cholecystitis sometimes, but most patient did not suffer from acute cholecystitis in the past, due to gallbladder persistent inflammatory, gallbladder wall can occur fiber to thicken, cicatrix shrinks, and causes atrophy of gallbladder, and blister cavities can be of completely closed, cause that gallbladder function goes down, even completely lose function.
Chronic cholecystitis is common in China, women sickness rate is high, and female and man's ratio are 2-3:1, the various complexity of its cause of disease, the factors such as including age, sex, race, dietary habit, obesity, heredity, biliary tract infection, cholestasis, mostly is the result of comprehensive factor effect.
Along with the improvement of our people's growth in the living standard and sanitary condition, national average life extends nearly ten years, and the sickness rate of cholelithiasis increases day by day, and especially big city is increased and become apparent from, and accounts for the 70% of whole cholelithiasis according to statistics.
Chronic cholecystitis has course of disease length and the feature of easily recurrence, and patient's thickening of capsule wall of gallbladder, muscular tissue atrophy, gallbladder contraction function goes down, and cardinal symptom shows as right flank portion pain discomfort, abdominal distention, belch, anorexia is greasy, gastral cavilty portion is scorching hot.Modern medicine is thought, the cause of disease of chronic cholecystitis is mainly calculus stimulation, antibacterial infection, parasite, chemical stimulation and acute cholecystitis recurrent exerbation delay etc., and to spirit, psychological, social factor is relevant.It it is a kind of clinical common and frequently-occurring disease.
The clinical manifestation of chronic cholecystitis is not true to type more, also inconspicuous.Being likely to often to have right upper quadrant of the abdomen dull pain, abdominal distention, belch at ordinary times, feel sick and the indigestion symptom such as anorexia greasy food, some patients then feel under right omoplate, right season rib or right waist etc. dull pain.Standing, moving and becoming apparent from after psychrolusia.There is mild tenderness under patient's upper right abdominal rib edge, or pressure have sense of discomfort.The visible gallbladder of ultrasound diagnosis is noticeable or increases, air emptying function obstacle.When oral cholecystographic agent finds there is calculus, then diagnosis may determine that.
Clinical manifestation according to chronic cholecystitis, this disease belongs to the categories such as motherland's medical science " gallbladder-distention ", " hypochondriac pain ", " jaundice ", says " gallbladder-distention person, pain over the hypochondrium is swollen, bitter in mouth, sighing frequently " such as " Ling Shu Miraculous Pivot or Divine Axis is swollen opinion ".Liver and gall are the exterior and the interior each other, liver controlling conveyance and dispersion, and gallbladder is the fu-organ that contains refined juice, and chronic cholecystitis disease position, at gallbladder, centered by liver and gall, relates to taste.The traditional Chinese medical science is thought to invade in many, the insect poison improper by eating and drinking without temperance, disorder of emotion, depression of liver-QI, work and rest of chronic cholecystitis morbidity etc. and is caused, and causes liver and gall disorder of QI movement, humid-heat stagnation, qi depression to blood stasis, and dysfunction of the spleen in transportation decocts bile, yin and yang qi and blood disorder.Basic pathogenesis can be attributed to damp-heat accumulation, disorder of QI movement.
Treatment for chronic cholecystitis, doctor trained in Western medicine mainly has expectant treatment and operative treatment, expectant treatment generally takes light diet, antibacterial therapy, anti-inflammatory and choleretic, spasmolysis and analgesia, litholytic therapy etc., if drug main Long-term Oral Cholagogue drug, such as XIAOYAN LIDAN PIAN, Fel Ursi capsule, state good anethol trithione, bilocid etc., there is the deficiencies such as unsatisfactory curative effect, treatment time length, side effect are big in it.Operative treatment is for extracing sufferer gallbladder.Chinese medicine treatment chronic cholecystitis method generally has for oral administration or external used medicine, medicament fumigating, acupuncture therapy etc., think that gallbladder is one of six internal organs, the six hollow viscera must keep its unobstructed, so-called " pain is then obstructed ", therefore Chinese traditional treatment is many with " leading to " for method, by methods such as clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, warming yang for activating qi-flowing, invigorating the spleen and benefiting QI, depressed liver-energy dispersing and function of gallbladder promoting, adjust the heresy of the stagnation of QI of smooth liver and gall, humid-heat stagnation of removing heat by catharsis, make poison heresy go and recover.
Chinese medicine is the precious legacy of China, by the adjustment effect to whole body entirety internal organs, improves body's immunity, plays the disease-resistant potential of human body.Active ingredient of Chinese herbs ubiquity immunological enhancement, immunosuppressant or dual regulation, biological effect is directly related with immunological network widely for it.Compared with synthetic drug, Chinese medicine has that untoward reaction is few, toxic and side effects is little and is not likely to produce the advantages such as drug resistance, is good biological response modifier.Therefore, herbal composite treatment chronic cholecystitis is adopted to become a new focus of people's research.
Summary of the invention
The present invention is directed to weak point of the prior art, it is provided that a kind of prepare simplicity, cost is low, evident in efficacy, the pharmaceutical composition for the treatment of chronic cholecystitis that has no side effect and preparation method thereof.
The above-mentioned purpose of the present invention is realized by following technical proposals:
A kind of pharmaceutical composition treating chronic cholecystitis, the crude drug of described pharmaceutical composition is made up of Herba Lysimachiae, Cortex Magnoliae Officinalis, Fructus Gardeniae (parched), Fructus Toosendan, Fructus Piperis Longi, Flos Rosae Rugosae, Endothelium Corneum Gigeriae Galli, Caulis Bambusae In Taenia, Herba Gentianopsis Paludosae, Concha Ostreae, Herba Lythri Salicariae, Radix Seu Caulis Mucunae Sempervirentis, Radix Sanguisorbae, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), Radix Cucurbitae, Semen Coicis, Herba Violae dissectae, Folium Et Cacumen Murrayae, Fructus Lycii, Semen Cassiae, Semen Vaccariae, Rhizoma Acori Graminei, Radix Rubiae, Ramulus Cinnamomi, Pericarpium Citri Reticulatae Viride, Fructus Crataegi, Radix Glycyrrhizae, Herba Taraxaci, Herba Hedyotidis Diffusae, Semen Plantaginis, Ramulus Salicis Babylonicae, Radix Polygoni Multiflori Preparata, Radix Saposhnikoviae.
nullFurther,Make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 12-20 part,Cortex Magnoliae Officinalis 10-16 part,Fructus Lycii 3-8 part,Fructus Gardeniae (parched) 5-12 part,Fructus Piperis Longi 12-17 part,Fructus Toosendan 7-12 part,Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 4-9 part,Endothelium Corneum Gigeriae Galli 15-20 part,Caulis Bambusae In Taenia 10-15 part,Concha Ostreae 8-12 part,Herba Lythri Salicariae 2-5 part,Flos Rosae Rugosae 3-7 part,Radix Seu Caulis Mucunae Sempervirentis 11-14 part,Radix Sanguisorbae 9-15 part,Semen Vaccariae 3-6 part,Radix Cucurbitae 8-13 part,Herba Violae dissectae 3-5 part,Folium Et Cacumen Murrayae 1-3 part,Rhizoma Acori Graminei 5-10 part,Herba Gentianopsis Paludosae 5-10 part,Radix Rubiae 13-16 part,Ramulus Cinnamomi 3-10 part,Pericarpium Citri Reticulatae Viride 8-13 part,Fructus Crataegi 3-5 part,Semen Coicis 1-3 part,Radix Glycyrrhizae 5-10 part,Semen Cassiae 3-6 part,Herba Taraxaci 8-13 part,Herba Hedyotidis Diffusae 3-5 part,Semen Plantaginis 11-15 part,Ramulus Salicis Babylonicae 5-10 part,Radix Polygoni Multiflori Preparata 2-5 part,Radix Saposhnikoviae 4-9 part.
Further, make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 12 parts, Cortex Magnoliae Officinalis 16 parts, Fructus Lycii 3 parts, Fructus Gardeniae (parched) 12 parts, Fructus Piperis Longi 12 parts, Fructus Toosendan 10 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 9 parts, Endothelium Corneum Gigeriae Galli 15 parts, Caulis Bambusae In Taenia 15 parts, Concha Ostreae 8 parts, Herba Lythri Salicariae 5 parts, Flos Rosae Rugosae 3 parts, Radix Seu Caulis Mucunae Sempervirentis 14 parts, Radix Sanguisorbae 9 parts, Semen Vaccariae 6 parts, Radix Cucurbitae 8 parts, Herba Violae dissectae 5 parts, Folium Et Cacumen Murrayae 1 part, Rhizoma Acori Graminei 10 parts, Herba Gentianopsis Paludosae 5 parts, 16 parts of Radix Rubiae, Ramulus Cinnamomi 10 parts, 8 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 parts, Semen Coicis 1 part, 10 parts of Radix Glycyrrhizae, Semen Cassiae 6 parts, Herba Taraxaci 8 parts, Herba Hedyotidis Diffusae 3 parts, Semen Plantaginis 15 parts, Ramulus Salicis Babylonicae 5 parts, Radix Polygoni Multiflori Preparata 3 parts, Radix Saposhnikoviae 5 parts.
Further, make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 20 parts, Cortex Magnoliae Officinalis 10 parts, Fructus Lycii 8 parts, Fructus Gardeniae (parched) 5 parts, Fructus Piperis Longi 17 parts, Fructus Toosendan 12 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 4 parts, Endothelium Corneum Gigeriae Galli 20 parts, Caulis Bambusae In Taenia 10 parts, Concha Ostreae 12 parts, Herba Lythri Salicariae 2 parts, Flos Rosae Rugosae 7 parts, Radix Seu Caulis Mucunae Sempervirentis 11 parts, Radix Sanguisorbae 15 parts, Semen Vaccariae 3 parts, Radix Cucurbitae 13 parts, Herba Violae dissectae 3 parts, Folium Et Cacumen Murrayae 3 parts, Rhizoma Acori Graminei 5 parts, Herba Gentianopsis Paludosae 10 parts, 13 parts of Radix Rubiae, Ramulus Cinnamomi 3 parts, 13 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 3 parts, Semen Coicis 3 parts, 5 parts of Radix Glycyrrhizae, Semen Cassiae 4 parts, Herba Taraxaci 10 parts, Herba Hedyotidis Diffusae 4 parts, Semen Plantaginis 13 parts, Ramulus Salicis Babylonicae 6 parts, Radix Polygoni Multiflori Preparata 4 parts, Radix Saposhnikoviae 8 parts.
Further, make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 13 parts, Cortex Magnoliae Officinalis 11 parts, Fructus Lycii 4 parts, Fructus Gardeniae (parched) 6 parts, Fructus Piperis Longi 13 parts, Fructus Toosendan 7 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 5 parts, Endothelium Corneum Gigeriae Galli 18 parts, Caulis Bambusae In Taenia 11 parts, Concha Ostreae 9 parts, Herba Lythri Salicariae 4 parts, Flos Rosae Rugosae 6 parts, Radix Seu Caulis Mucunae Sempervirentis 12 parts, Radix Sanguisorbae 13 parts, Semen Vaccariae 4 parts, Radix Cucurbitae 9 parts, Herba Violae dissectae 4 parts, Folium Et Cacumen Murrayae 2 parts, Rhizoma Acori Graminei 6 parts, Herba Gentianopsis Paludosae 6 parts, 14 parts of Radix Rubiae, Ramulus Cinnamomi 5 parts, 10 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 4 parts, Semen Coicis 2 parts, 6 parts of Radix Glycyrrhizae, Semen Cassiae 5 parts, Herba Taraxaci 12 parts, Herba Hedyotidis Diffusae 3 parts, Semen Plantaginis 12 parts, Ramulus Salicis Babylonicae 9 parts, Radix Polygoni Multiflori Preparata 4 parts, Radix Saposhnikoviae 7 parts.
Further, make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 17 parts, Cortex Magnoliae Officinalis 15 parts, Fructus Lycii 7 parts, Fructus Gardeniae (parched) 11 parts, Fructus Piperis Longi 16 parts, Fructus Toosendan 8 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 8 parts, Endothelium Corneum Gigeriae Galli 16 parts, Caulis Bambusae In Taenia 14 parts, Concha Ostreae 11 parts, Herba Lythri Salicariae 3 parts, Flos Rosae Rugosae 5 parts, Radix Seu Caulis Mucunae Sempervirentis 13 parts, Radix Sanguisorbae 14 parts, Semen Vaccariae 5 parts, Radix Cucurbitae 12 parts, Herba Violae dissectae 3 parts, Folium Et Cacumen Murrayae 1 part, Rhizoma Acori Graminei 10 parts, Herba Gentianopsis Paludosae 9 parts, 13 parts of Radix Rubiae, Ramulus Cinnamomi 7 parts, 11 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 3 parts, Semen Coicis 1 part, 10 parts of Radix Glycyrrhizae, Semen Cassiae 4 parts, Herba Taraxaci 11 parts, Herba Hedyotidis Diffusae 4 parts, Semen Plantaginis 14 parts, Ramulus Salicis Babylonicae 8 parts, Radix Polygoni Multiflori Preparata 3 parts, Radix Saposhnikoviae 6 parts.
Further, make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 15 parts, Cortex Magnoliae Officinalis 12 parts, Fructus Lycii 5 parts, Fructus Gardeniae (parched) 9 parts, Fructus Piperis Longi 15 parts, Fructus Toosendan 9 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 7 parts, Endothelium Corneum Gigeriae Galli 19 parts, Caulis Bambusae In Taenia 13 parts, Concha Ostreae 10 parts, Herba Lythri Salicariae 4 parts, Flos Rosae Rugosae 4 parts, Radix Seu Caulis Mucunae Sempervirentis 11 parts, Radix Sanguisorbae 11 parts, Semen Vaccariae 5 parts, Radix Cucurbitae 10 parts, Herba Violae dissectae 5 parts, Folium Et Cacumen Murrayae 3 parts, Rhizoma Acori Graminei 8 parts, Herba Gentianopsis Paludosae 8 parts, 14 parts of Radix Rubiae, Ramulus Cinnamomi 9 parts, 12 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 parts, Semen Coicis 3 parts, 8 parts of Radix Glycyrrhizae, Semen Cassiae 6 parts, Herba Taraxaci 9 parts, Herba Hedyotidis Diffusae 5 parts, Semen Plantaginis 12 parts, Ramulus Salicis Babylonicae 7 parts, Radix Polygoni Multiflori Preparata 5 parts, Radix Saposhnikoviae 9 parts.
Further, make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 19 parts, Cortex Magnoliae Officinalis 14 parts, Fructus Lycii 6 parts, Fructus Gardeniae (parched) 7 parts, Fructus Piperis Longi 14 parts, Fructus Toosendan 9 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 6 parts, Endothelium Corneum Gigeriae Galli 17 parts, Caulis Bambusae In Taenia 13 parts, Concha Ostreae 10 parts, Herba Lythri Salicariae 4 parts, Flos Rosae Rugosae 4 parts, Radix Seu Caulis Mucunae Sempervirentis 11 parts, Radix Sanguisorbae 11 parts, Semen Vaccariae 5 parts, Radix Cucurbitae 10 parts, Herba Violae dissectae 5 parts, Folium Et Cacumen Murrayae 3 parts, Rhizoma Acori Graminei 8 parts, Herba Gentianopsis Paludosae 8 parts, 14 parts of Radix Rubiae, Ramulus Cinnamomi 4 parts, 9 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 parts, Semen Coicis 3 parts, 8 parts of Radix Glycyrrhizae, Semen Cassiae 3 parts, Herba Taraxaci 8 parts, Herba Hedyotidis Diffusae 5 parts, Semen Plantaginis 15 parts, Ramulus Salicis Babylonicae 7 parts, Radix Polygoni Multiflori Preparata 2 parts, Radix Saposhnikoviae 4 parts.
The preparation method that the invention still further relates to a kind of pharmaceutical composition treating chronic cholecystitis, comprises the steps:
(1) taking each medical material of components by weight percent in arbitrary described pharmaceutical composition, first time decocts the water boiling and extraction of 10-15 times that adds medical material gross weight, decocts 1-2 hour: second time adds the water of 8-12 times amount, decocts 1-1.2h, leaches medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 0.8-1.2h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.10-1.30;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 60-75%, to stand 24-48 hour, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 50-60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) dry extract that step (2) prepares is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, granule can be prepared;Or the dry extract that step (2) prepares be dry, pulverize, make powder;Or dry extract step (2) prepared is pulverized, add appropriate micropowder silica gel, α-galactose mixing, with ethanol for wetting agent, granulate, dry, granulate, encapsulated, prepare capsule;Or dry extract step (2) prepared is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, tabletting, prepare tablet;Or to above-mentioned steps (2) obtain centrifugal after concentrated solution in add suitable amount of sucrose, essence mixing, sterilizing, fill, prepare medicinal liquid agent.
The invention still further relates to the application in treatment chronic cholecystitis medicine of a kind of described pharmaceutical composition.
The pharmaceutical composition for the treatment of chronic cholecystitis provided by the present invention, it gives full play to the property of medicine of each component with common Chinese herbal medicine for raw material:
Herba Lysimachiae: sweet in the mouth, micro-hardship, cool in nature.Return liver, gallbladder, kidney, bladder warp.Function cures mainly: relieving stranguria by diuresis;Heat-clearing and toxic substances removing;Dissipating blood stasis for subsidence of swelling.Cure mainly liver and gall and urinary system calculus;Pyretic stranguria;Oedema due to nephritis;Jaundice due to damp-heat;Sore carbuncle;Venom;Traumatic injury.
Cortex Magnoliae Officinalis, bitter in the mouth, pungent, warm in nature;Return spleen, stomach, lung, large intestine channel.Having circulation of qi promoting removing food stagnancy, dampness is removed full, effect of lowering the adverse QI to relieve asthma.
Fructus Gardeniae (parched), bitter, cold.GUIXIN, lung, tri-jiao channel.Cure mainly pathogenic fire purging relieving restlessness, clearing away heat and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body.Vexed for calentura, jaundice dark coloured urine, blood strangury and dry pain, heat in blood tells nosebleed, conjunctival congestion and swelling pain, pathogenic fire,toxin and furuncles;External treatment bruise pain.
Fructus Toosendan: Chinese crude drug, for the mature fruit of Meliaceae deciduous tree toosendanin, cold in nature, bitter in the mouth, is the one of qi-activating drug.There are soothing liver-QI promoting the circulation of QI to relieve pain, the drug effect of anthelmintic.For the breast side of body, abdominal distention, colic, abdominal pain due to worm stagnation.But also be make the efficient important source material without the free of contamination novel plant pesticide of residual hazard.Fructus Toosendan bitter cold settles, and mainly enters Liver Channel, catharsis liver-heat, promoting the circulation of QI to relieve pain, controls the stagnation of QI and has demonstrate,proving of heat especially suitable.
Fructus Piperis Longi: for analgesia stomachic, the big temperature of acrid in the mouth, nontoxic.For stomachache, acid regurgitation, diarrhoea, angina pectoris, nervous headache and toothache etc. that cold syndrome of the stomach causes.Warming the middle warmer and descending qi, mends waist foot, kills stink smell, help digestion, and except stomach is cold, scrotal hernia and chest and abdomen are bitterly.Control cholera cold air, pained vim and vigour, watery diarrhea dysentery of deficiency type, vomiting acid regurgitation, puerperal dysentery, share better with Resina Ferulae.With Fructus Chebulae, Radix Ginseng, Cortex Cinnamomi, Rhizoma Zingiberis, control internal organs cold caused by deficiency borborygmus, control again headache, nasal obstruction, tenderness.The fire of active spleen lung, multiplex makes us blurred vision.Its root name Bi Bohai Sea does not have, acrid in the mouth, warm in nature and, nontoxic.Treatment five kinds of strain and seven kinds of impairment, cold air is vomitted, trusted subordinate's distension, dyspepsia, the embedding edema of polyhidrosis around the external genitals hernia, married woman's infertility.Control waist kidney cold, except vim and vigour.
Flos Rosae Rugosae: road in " book on Chinese herbal medicine text ": " Flos Rosae Rugosae, turbid clearly and not, and and violent, easing the affected liver is waken up stomach, and thin gas is invigorated blood circulation, and a surname is logical stops up stagnant and that absolutely not pungent temperature is just dry fraud, disconnected pushes away among edema caused by disorder of QI medicine, has prompt effect most and the most tractable, fragrant all product, and there is no equal ".Sweet and slightly bitter taste, slightly warm in nature, return liver, spleen, stomach warp.
Endothelium Corneum Gigeriae Galli: the taste of chicken are also.In have porcelain stone, copper, ferrum all can digest, its kind blood stasis dispelling is amassed known.(taste) are placed in the middle burnt to lift gasification, if there being the stasis of blood to amass, gasification can not lift, and is easily cause distension, is organotherapy with Endothelium Corneum Gigeriae Galli.If again with Rhizoma Atractylodis Macrocephalae decile use, for the key medicine that the digestion stasis of blood is long-pending, the more quality goods of strengthening the spleen and stomach, taste are healthy and strong, and the benefit energy transporting efficacy of a drug is with removing food stagnancy also.Not only can diabetes with polyphagia as the prominent symptom stomach long-pending, no matter internal organs where has long-pending, and Endothelium Corneum Gigeriae Galli all can disappear it, is with man's mass beside the umbilicus, woman's lump in the abdomen, takes it for a long time, all can cure.The card of all asthenia again, the many stasis of bloods of its meridians are stagnant, add Endothelium Corneum Gigeriae Galli in tonic, and the stasis of blood to change its meridians is stagnant, and disease begins more.
Caulis Bambusae In Taenia: nature and flavor cold nature, sweet in the mouth.Function cures mainly: removing heat-phlegm, relieves restlessness and prevents vomiting.Expectorant, dysphoria with smothery sensation vomiting, palpitation with fear insomnia, middle wind-phlegm fan, aphasia with stiff tongue, gastropyretic vomiting, pregnancy reactions, frequent fetal movement is held under the arm for phlegm-heat cough, gallbladder fire.
Herba Gentianopsis Paludosae: herb treatment jaundice, liver and gall heat, headache, lung-heat, gastric heat, has a fever " illiteracy plants medicine will ".Craze for Japanese pop culture-Te wood day-ground lattice reach, and prick various places each: herb is for " uncommon day " hot eye, urine, Dermal icterus, new liver-heat for a long time, hepatic injury, and liver blood rises, " uncommon day " property pneumonopathy, have a headache, vomiting of drinking, gastric acid pain " ethnic drug will three ".Craze for Japanese pop culture spy's wood that-ground lattice: curing mainly liver and gall heat, jaundice, heat in blood is had a headache, fever, xerostomia, gastric heat.
Concha Ostreae: " Bencao Jingshu ": Concha Ostreae salty in the mouth is put down, feeble QI is trembled with fear, nontoxic, enters foot few the moon, the moon of fainting, shaoyang channel.Its main typhoid fever cold and heat, pyrexial malaria be voluminous, frightened gas of being enraged, stays heat to remove under indefinite, stuffy sensation with restlessness, depressed pained, the heart side of body cards such as painful abdominal mass heat in joint, and all liver and gall two are through for disease.Two are subject to cold-evil through the winter, then be typhoid fever cold and heat;Being attacked by pathogenic heat in summer, then be that pyrexial malaria is voluminous;Evil lie prostrate not go out, then hot go in joint indefinite;Two do not dissipate through evil strongly fragrant, then the lower painful abdominal mass of the heart side of body;Very, then frightened gas of being enraged, stuffy sensation with restlessness is depressed pained for pathogenic heat heat.The salty gas of these flavour of a drug is trembled with fear, and enters two warps and removes cold and heat pathogen, then battalion defends logical, arrests and relaxes, and all cards recover invariably.Few the moon has heat, then woman be that leukorrhagia is red in vain, and man, for letting out essence, solves the heat lacking the moon, and can hold back arresting seminal emission gas, thus main also.
Herba Lythri Salicariae is the herb of Lythraceae plant Herba Lythri Salicariae.Sweet in the mouth, hardship, cold in nature.Return large intestine, Liver Channel.Function removing blood stasis with potent drugs stimulates the menstrual flow, clearing away heat and cooling blood, heat clearing away poison.
Radix Seu Caulis Mucunae Sempervirentis is the stem of the evergreen mucuna of leguminous plant.Bitter in the mouth, warm in nature.Return liver, stomach warp.Function blood circulation promoting and blood stasis dispelling, promoting blood flow to regulate menstruation, promoting the circulation of blood is enriched blood, dredge the meridian passage.For traumatic injury, rheumatalgia, numbness, stimulate the menstrual flow, amenorrhea.
Radix Sanguisorbae property of medicine picric acid;Cold;Nontoxic, return liver;Lung;Kidney;Large intestine channel, effect cooling blood for hemostasis, heat-clearing and toxic substances removing, sore of subsiding a swelling.Effect classification hemorrhage;Blood-cooling hemostatic.Cure mainly haematemesis, spitting of blood, epistaxis, hematuria, have blood in stool, hemorrhoidal bleeding, dysentery, metrorrhagia, leucorrhea with red and white discharge, sore, carbuncle and painful swelling, eczema, pudendal pruritus, burn due to hot liquid or fire, snake bite and insect sting.
Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) is the herb of Ofthe Primulaceae tiger tail Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis).Bitter in the mouth, pungent, property is put down.Return liver, spleen channel.Function promoting blood circulation to remove blood stasis, clearing away heat-damp and promoting diuresis, removing toxicity for eliminating carbuncles.
Radix Cucurbitae is the root of cucurbitaceous plant Fructus Cucurbitae moschatae.Sweet in the mouth, light, property is put down.Return liver, bladder warp.Function dampness removing heat, clear jaundice, promoting lactation, logical wet pouring.
Semen Coicis: enter spleen, lung, kidney channel.Spleen invigorating, tonifying the lung, heat clearing away, dampness removing.Control and have loose bowels, arthralgia chiefly caused by damp pathogen, muscle arteries and veins contracture, joint stuffiness, edema, beriberi, consumptive lung disease, lung abscess, acute appendicitis, stranguria with turbid discharge, leucorrhea.
Herba Violae dissectae is the Herb of Violaceae plant decomposite leaf common violet.Bitter in the mouth, cold in nature.Enter the heart, gallbladder, spleen, Liver Channel.Function heat-clearing and toxic substances removing, repercussive eliminating stagnation, detumescence poison.
Folium Et Cacumen Murrayae is leaf and the band leaf twig of rutaceae Folium Et Cacumen Murrayae and Murraya paniculata (L.) Jack..Acrid in the mouth, micro-hardship, warm in nature.GUIXIN, liver, lung meridian.Function promoting blood circulation to remove blood stasis, promoting the circulation of QI to relieve pain.
Fructus Lycii, sweet, flat.Return liver, kidney channel.Nourishing the liver and kidney, benefit intensive culture blood, improving eyesight removing nebula, nourishing the lung to arrest cough.The diseases such as curing mainly the atrophic debility of bones of suffering from a deficiency of the kidney, impotence and seminal emission, fertility of a specified duration, senilism senilism, early whitening of beard and hair, blood deficiency and yellow complexion, puerperal, breast was few, poor vision, interior external oculopathy eye, and interior-heat is quenched one's thirst, consumptive fever hectic fever due to YIN-deficiency, and chronic consumptive disease is coughed, the few expectorant of dry cough.
Semen Cassiae is the mature seed of leguminous plant Semen Cassiae, is also known as Semen Cassiae.Shennong's Herbal is recorded Semen Cassiae sweetness and bitterness and is slightly cold, and returns liver, gallbladder, kidney three warp, has liver heat removing and eyesight improving, loosening bowel to relieve constipation, the function of lipid-lowering weight-reducing, can be used for dizziness of having a headache, and conjunctival congestion is dim-sighted, constipation etc., in recent years clinically again for the treatment of hypertension.Semen Cassiae, containing anthraglycosides material, produces rheum emodin, physcione, chrysophanic acid, chrysophanol and glucose etc. after decomposition.It is demonstrated experimentally that Semen Cassiae has blood pressure lowering, blood fat reducing, the effect such as antibacterial, being used for treating hyperlipemia has certain curative effect.Except medicinal ingredient, Semen Cassiae is possibly together with multivitamin and abundant aminoacid, carbohydrate etc..
Semen Vaccariae: bitter in the mouth, property are flat, return stomach warp, have effect of promoting blood circulation to restore menstrual flow stimulating milk secretion, is good at promoting blood circulation, goes and does not walk, walks and do not keep, and upper energy promoting lactation, lower energy leads to amenorrhea.
Rhizoma Acori Graminei: pungent, bitter, temperature.GUIXIN, stomach warp.Effect with cure mainly: removing dampness whet the appetite, eliminating phlegm of having one's ideas straightened out, refreshment Fructus Alpiniae Oxyphyllae.Not hungry for gastral cavity painful abdominal mass, a mouthful dysentery of keeping silent, the insane disease of coma, forgetful deafness.
Radix Rubiae: cold in nature, bitter in the mouth, there is cooling blood for hemostasis, effect that blood stasis dispelling stimulates the menstrual flow, especially suitable for the hemorrhage of bleeding due to blood-heat, the congestion person that holds concurrently, for stasis of blood stagnate-closed warp, postpartum stagnation stomachache, treating swelling and pain by traumatic injury, rheumatic arthralgia etc. are demonstrate,proved.
Ramulus Cinnamomi: nature and flavor acrid, sweet, warm, GUIXIN, lung, bladder warp;Effect: diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain, must not warm logical card for yang deficiency.
Pericarpium Citri Reticulatae Viride: bitter in the mouth, pungent, warm in nature, enter liver, gallbladder, stomach warp, there is the effect that easypro gallbladder dispelling the stagnated QI, removing food stagnancyization are stagnant, for stagnation of QI due to dyspepsia, abdominal distention, infantile malnutrition, old man stops eating abdominal distention, gastrointestinal tract is had the stimulation of gentleness, can facilitating digestion liquid secretion and get rid of internal gas, again can diastole gastrointestinal smooth muscle, main manifestations be adjust gastrointestinal function effect.
Fructus Crataegi is the fruit of Flos Rosae Multiflorae tannin plant Fructus Crataegi or Crataegi cuneatae, and it is sour, sweet, tepor, enters spleen, stomach, Liver Channel, have help digestion long-pending, dissipating blood stasis blood, diuresis, effect of antidiarrheal.After human body takes Fructus Crataegi, by increasing capacitance it is possible to increase the activity of enzyme in stomach, promote food digestion, circulation of qi promoting dissipating blood stasis, be beneficial to the meat that disappears and amass.
Radix Glycyrrhizae: sweet in the mouth, returns 12 warps.Have removing toxic substances, eliminate the phlegm, pain relieving, spasmolytic is so that the pharmacological action such as anticancer.In the traditional Chinese medical science, Radix Glycyrrhizae invigorating the spleen and replenishing QI, to grow and cough lung moistening, emergency is detoxified, and is in harmonious proportion hundred medicines.
Herba Taraxaci: for feverfew Herba Taraxaci TaraxacummongolicumHand.-Mazz., alkali ground Herba Taraxaci TaraxacumsinicumKitag. or the dry herb belonging to several plants together.Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, inducing diuresis for treating stranguria syndrome.For furuncle swelling toxin, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, lung abscess, acute appendicitis, jaundice due to damp-heat, the puckery pain of pyretic stranguria.
Herba Hedyotidis Diffusae: bitter in the mouth, sweet, cold in nature, enter the heart, liver, spleen, large intestine channel, there is heat-clearing and toxic substances removing, the effect of promoting diuresis to eliminate damp pathogen, for dyspnea and cough due to lung-heat, laryngopharynx swelling and pain, acute appendicitis, furuncle and phyma skin infection, venom, the puckery pain of pyretic stranguria, edema, dysentery, enteritis, jaundice due to damp-heat, the card such as cancerous protuberance.
Semen Plantaginis: clearing away heat and promoting diuresis;Eliminating dampness by diuresis antidiarrheal;Improving eyesight;Eliminate the phlegm.Cure mainly: main dysuria;Stranguria with turbid discharge leukorrhagia;Edema distension;Heat-damp in summer dysentery;Conjunctival congestion is hidden from view;Expectorant heat syndrome cough is breathed heavily.Select the seed for Plantaginaceae plant Herba Plantaginis Big Semen Plantaginis and Plantago depressa Willd.
Ramulus Salicis Babylonicae: dispel the wind, diuresis, pain relieving, detumescence.Dispelling the wind and dampness pathogens arthralgia pain, gonorrhea, nebulousurine, urinary obstruction, infectious hepatitis, swelling due to wind, furuncle, erysipelas, dental caries, swelling of the gum.Select the dry branch of Salicaceous Plants Salix babylonica L..
Radix Polygoni Multiflori Preparata: for the Preparation process product of the dried root of polygonum multiflorum thunb PolygonummultiflorumThunb..Nature and flavor are bitter, sweet, puckery, tepor.Return liver, the heart, kidney channel.Effect: invigorating the liver and kidney, benefiting essence-blood, crow beard and hair, bone and muscle strengthening.
Radix Saposhnikoviae, nature and flavor: acrid in the mouth, sweet, slightly warm in nature, there is expelling pathogenic wind from the body surface, effect that removing dampness to relieve pain, relieving convulsion are jerked surely, be used for treating diseases caused by exogenous pathogenic factor exterior syndrome, rubella pruritus, rheumatic arthralgia, tetanus.
The traditional Chinese medical science is thought, chronic cholecystitis, belongs to the sick category such as the traditional Chinese medical science " gallbladder-distention ", " hypochondriac pain ".The traditional Chinese medical science thinks that liver is one of the five internal organs, main store blood, main catharsis, and property happiness bar reaches and dislikes depression.Gallbladder is internal organs, main store essential substances juice, to lead to for use, suitable to reduce to.Liver and gall are the exterior and the interior each other, and bile leading to drops, and depends on the catharsis of liver, and gallbladder internal organs function is normal, is conducive to the bar of liver to reach.If feelings will is not relaxed, irritability stasis, or daily life is careless, damp and hot heresy invasion and attack gallbladder internal organs;Or eating and drinking without temperance, have a liking for the product of greasy delicious food, lead to damp and hot, interior stream gallbladder internal organs, all can cause liver and gall and become estranged, logical drop unfavorable, mechanism of qi retardance and raw pain, swollen all diseases.Moist sticky, in addition liver and gall depression and stagnation of QI, the symptoms such as transporting and transforming function of the spleen and stomach is not good for, inside and outside phase factor, often causes protracted inflammation or recurrent exerbation, and touching difficulty more, then becomes liver and gall to become estranged, the damp and hot card being detained, and upper abdomen or distending pain over the hypochondrium occurs, right pain in the shoulder and back, abdominal distention and little diet, bitter taste, greasy fur.In the course of disease, liver and gall are become estranged, irritability stasis, may result in insufficiency of the spleen transporting too late, water-damp retention, and damp-stagnancy heat-transformation, may result in again stagnation of liver-QI and lose thin, and logical the dropping of bile is obstructed, and is thusly-formed vicious cycle, then disease is delayed repeatedly, not easily cures.Pathogenesis it is critical only that liver and gall are become estranged, and damp and hot is detained, and medicine for treatment, outside depressed liver-energy dispersing and function of gallbladder promoting, should pay attention to invigorating spleen to remove dampness, makes liver dredge spleen fortune, and mechanism of qi bar reaches, transporting and transforming function of the spleen and stomach is had the right, then damp and hot raw, gallbladder internal organs is peaceful clearly, radically reform thus reaching to effect a permanent cure, treating both the principal and secondary aspects of a disease purpose.
The pharmaceutical composition compatibility of the treatment chronic cholecystitis of the present invention is based on Chinese medicine " monarch " principle, all medicines share can clearing liver-gallbladder, soothing the liver circulation of qi promoting, regulating functional activities of qi, effect of heat-clearing and toxic substances removing, tranquilizing by nourishing the heart, invigorating the spleen and benefiting QI, clearing heat secreting bile played altogether by all medicines, reach the purpose for the treatment of chronic cholecystitis, and overcome the defect of the length course for the treatment of that Modern medical therapy chronic cholecystitis has, poor effect, easily recurrence.
Detailed description of the invention
For making the purpose of the embodiment of the present invention, technical scheme and advantage clearly, below in conjunction with embodiment, technical scheme is clearly and completely described.Obviously, described embodiment is the part of the present invention, rather than whole embodiments.Based on described embodiments of the invention, the every other embodiment that those of ordinary skill in the art obtain under the premise without creative work, broadly fall into the scope of protection of the invention.Except as otherwise noted, the percent of the amount of alcohol in the present invention is percentage by volume, and v/v represents the volume ratio of solution.
Embodiment 1:
A kind of pharmaceutical composition treating chronic cholecystitis of the present invention, take following traditional Chinese medicine raw medicine: Herba Lysimachiae 12 grams, Cortex Magnoliae Officinalis 16 grams, Fructus Lycii 3 grams, Fructus Gardeniae (parched) 12 grams, Fructus Piperis Longi 12 grams, Fructus Toosendan 10 grams, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 9 grams, Endothelium Corneum Gigeriae Galli 15 grams, Caulis Bambusae In Taenia 15 grams, Concha Ostreae 8 grams, Herba Lythri Salicariae 5 grams, Flos Rosae Rugosae 3 grams, Radix Seu Caulis Mucunae Sempervirentis 14 grams, Radix Sanguisorbae 9 grams, Semen Vaccariae 6 grams, Radix Cucurbitae 8 grams, Herba Violae dissectae 5 grams, Folium Et Cacumen Murrayae 1 gram, Rhizoma Acori Graminei 10 grams, Herba Gentianopsis Paludosae 5 grams, 16 grams of Radix Rubiae, Ramulus Cinnamomi 10 grams, 8 grams of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 grams, Semen Coicis 1 gram, 10 grams of Radix Glycyrrhizae, Semen Cassiae 6 grams, Herba Taraxaci 8 grams, Herba Hedyotidis Diffusae 3 grams, Semen Plantaginis 15 grams, Ramulus Salicis Babylonicae 5 grams, Radix Polygoni Multiflori Preparata 3 grams, Radix Saposhnikoviae 5 grams.
The preparation method of described Chinese medicine composition is:
(1) taking each medical material of components by weight percent in described Chinese medicine composition, first time decocts the water boiling and extraction of 10-15 times that adds medical material gross weight, decocts 1 hour: second time adds the water of 8 times amount, decocts 1h, leaches medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 1.2h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.30;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 60-75%, to stand 24 hours, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) dry extract that step (2) prepares is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, granule can be prepared.
Embodiment 2:
A kind of pharmaceutical composition treating chronic cholecystitis of the present invention, take following traditional Chinese medicine raw medicine: Herba Lysimachiae 20 grams, Cortex Magnoliae Officinalis 10 grams, Fructus Lycii 8 grams, Fructus Gardeniae (parched) 5 grams, Fructus Piperis Longi 17 grams, Fructus Toosendan 12 grams, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 4 grams, Endothelium Corneum Gigeriae Galli 20 grams, Caulis Bambusae In Taenia 10 grams, Concha Ostreae 12 grams, Herba Lythri Salicariae 2 grams, Flos Rosae Rugosae 7 grams, Radix Seu Caulis Mucunae Sempervirentis 11 grams, Radix Sanguisorbae 15 grams, Semen Vaccariae 3 grams, Radix Cucurbitae 13 grams, Herba Violae dissectae 3 grams, Folium Et Cacumen Murrayae 3 grams, Rhizoma Acori Graminei 5 grams, Herba Gentianopsis Paludosae 10 grams, 13 grams of Radix Rubiae, Ramulus Cinnamomi 3 grams, 13 grams of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 3 grams, Semen Coicis 3 grams, 5 grams of Radix Glycyrrhizae, Semen Cassiae 4 grams, Herba Taraxaci 10 grams, Herba Hedyotidis Diffusae 4 grams, Semen Plantaginis 13 grams, Ramulus Salicis Babylonicae 6 grams, Radix Polygoni Multiflori Preparata 4 grams, Radix Saposhnikoviae 8 grams.
Wherein, the preparation method of described Chinese medicine composition is:
(1) taking each medical material of components by weight percent in described Chinese medicine composition, first time decocts the water boiling and extraction of 10-15 times that adds medical material gross weight, decocts 1-2 hour: second time adds the water of 12 times amount, decocts 1.2h, leaches medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 0.8-1.2h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.10;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 60-75%, to stand 24-48 hour, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 50-60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) dry extract that step (2) prepares be dry, pulverize, make powder.
Embodiment 3:
A kind of pharmaceutical composition treating chronic cholecystitis of the present invention, take following traditional Chinese medicine raw medicine: Herba Lysimachiae 13 grams, Cortex Magnoliae Officinalis 11 grams, Fructus Lycii 4 grams, Fructus Gardeniae (parched) 6 grams, Fructus Piperis Longi 13 grams, Fructus Toosendan 7 grams, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 5 grams, Endothelium Corneum Gigeriae Galli 18 grams, Caulis Bambusae In Taenia 11 grams, Concha Ostreae 9 grams, Herba Lythri Salicariae 4 grams, Flos Rosae Rugosae 6 grams, Radix Seu Caulis Mucunae Sempervirentis 12 grams, Radix Sanguisorbae 13 grams, Semen Vaccariae 4 grams, Radix Cucurbitae 9 grams, Herba Violae dissectae 4 grams, Folium Et Cacumen Murrayae 2 grams, Rhizoma Acori Graminei 6 grams, Herba Gentianopsis Paludosae 6 grams, 14 grams of Radix Rubiae, Ramulus Cinnamomi 5 grams, 10 grams of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 4 grams, Semen Coicis 2 grams, 6 grams of Radix Glycyrrhizae, Semen Cassiae 5 grams, Herba Taraxaci 12 grams, Herba Hedyotidis Diffusae 3 grams, Semen Plantaginis 12 grams, Ramulus Salicis Babylonicae 9 grams, Radix Polygoni Multiflori Preparata 4 grams, Radix Saposhnikoviae 7 grams.
Wherein, the preparation method of described Chinese medicine composition is:
(1) taking each medical material of components by weight percent in described Chinese medicine composition, first time decocts the water boiling and extraction of 10-15 times that adds medical material gross weight, decocts 1-2 hour: second time adds the water of 8-12 times amount, decocts 1-1.2h, leaches medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 0.8h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.15;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 60-75%, to stand 48 hours, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 50-60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) dry extract that step (2) prepares is pulverized, add appropriate micropowder silica gel, α-galactose mixing, with ethanol for wetting agent, granulate, dry, granulate, encapsulated, prepare capsule.
Embodiment 4:
A kind of pharmaceutical composition treating chronic cholecystitis of the present invention, take following traditional Chinese medicine raw medicine: Herba Lysimachiae 17 grams, Cortex Magnoliae Officinalis 15 grams, Fructus Lycii 7 grams, Fructus Gardeniae (parched) 11 grams, Fructus Piperis Longi 16 grams, Fructus Toosendan 8 grams, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 8 grams, Endothelium Corneum Gigeriae Galli 16 grams, Caulis Bambusae In Taenia 14 grams, Concha Ostreae 11 grams, Herba Lythri Salicariae 3 grams, Flos Rosae Rugosae 5 grams, Radix Seu Caulis Mucunae Sempervirentis 13 grams, Radix Sanguisorbae 14 grams, Semen Vaccariae 5 grams, Radix Cucurbitae 12 grams, Herba Violae dissectae 3 grams, Folium Et Cacumen Murrayae 1 gram, Rhizoma Acori Graminei 10 grams, Herba Gentianopsis Paludosae 9 grams, 13 grams of Radix Rubiae, Ramulus Cinnamomi 7 grams, 11 grams of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 3 grams, Semen Coicis 1 gram, 10 grams of Radix Glycyrrhizae, Semen Cassiae 4 grams, Herba Taraxaci 11 grams, Herba Hedyotidis Diffusae 4 grams, Semen Plantaginis 14 grams, Ramulus Salicis Babylonicae 8 grams, Radix Polygoni Multiflori Preparata 3 grams, Radix Saposhnikoviae 6 grams.
Wherein, the preparation method of described Chinese medicine composition is:
(1) taking each medical material of components by weight percent in described Chinese medicine composition, first time decocts the water boiling and extraction of 15 times that add medical material gross weight, decocts 1-2 hour: second time adds the water of 8-12 times amount, decocts 1-1.2h, leaches medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 0.8-1.2h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.10-1.30;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 60-75%, to stand 24-48 hour, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 50-60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) dry extract that step (2) prepares is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, tabletting, prepare tablet.
Embodiment 5:
A kind of pharmaceutical composition treating chronic cholecystitis of the present invention, take following traditional Chinese medicine raw medicine: Herba Lysimachiae 15 grams, Cortex Magnoliae Officinalis 12 grams, Fructus Lycii 5 grams, Fructus Gardeniae (parched) 9 grams, Fructus Piperis Longi 15 grams, Fructus Toosendan 9 grams, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 7 grams, Endothelium Corneum Gigeriae Galli 19 grams, Caulis Bambusae In Taenia 13 grams, Concha Ostreae 10 grams, Herba Lythri Salicariae 4 grams, Flos Rosae Rugosae 4 grams, Radix Seu Caulis Mucunae Sempervirentis 11 grams, Radix Sanguisorbae 11 grams, Semen Vaccariae 5 grams, Radix Cucurbitae 10 grams, Herba Violae dissectae 5 grams, Folium Et Cacumen Murrayae 3 grams, Rhizoma Acori Graminei 8 grams, Herba Gentianopsis Paludosae 8 grams, 14 grams of Radix Rubiae, Ramulus Cinnamomi 9 grams, 12 grams of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 grams, Semen Coicis 3 grams, 8 grams of Radix Glycyrrhizae, Semen Cassiae 6 grams, Herba Taraxaci 9 grams, Herba Hedyotidis Diffusae 5 grams, Semen Plantaginis 12 grams, Ramulus Salicis Babylonicae 7 grams, Radix Polygoni Multiflori Preparata 5 grams, Radix Saposhnikoviae 9 grams.
Wherein, the preparation method of described Chinese medicine composition is:
(1) taking each medical material of components by weight percent in described Chinese medicine composition, first time decocts the water boiling and extraction of 10-15 times that adds medical material gross weight, decocts 1.5 hours: second time adds the water of 8 times amount, decocts 1-1.2h, leaches medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 0.8-1.2h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.10-1.30;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 75%, to stand 24-48 hour, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 50-60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) to above-mentioned steps (2) obtain centrifugal after concentrated solution in add suitable amount of sucrose, essence mixing, sterilizing, fill, prepare medicinal liquid agent.
Embodiment 6:
A kind of pharmaceutical composition treating chronic cholecystitis of the present invention, take following traditional Chinese medicine raw medicine: Herba Lysimachiae 19 grams, Cortex Magnoliae Officinalis 14 grams, Fructus Lycii 6 grams, Fructus Gardeniae (parched) 7 grams, Fructus Piperis Longi 14 grams, Fructus Toosendan 9 grams, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 6 grams, Endothelium Corneum Gigeriae Galli 17 grams, Caulis Bambusae In Taenia 13 grams, Concha Ostreae 10 grams, Herba Lythri Salicariae 4 grams, Flos Rosae Rugosae 4 grams, Radix Seu Caulis Mucunae Sempervirentis 11 grams, Radix Sanguisorbae 11 grams, Semen Vaccariae 5 grams, Radix Cucurbitae 10 grams, Herba Violae dissectae 5 grams, Folium Et Cacumen Murrayae 3 grams, Rhizoma Acori Graminei 8 grams, Herba Gentianopsis Paludosae 8 grams, 14 grams of Radix Rubiae, Ramulus Cinnamomi 4 grams, 9 grams of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 grams, Semen Coicis 3 grams, 8 grams of Radix Glycyrrhizae, Semen Cassiae 3 grams, Herba Taraxaci 8 grams, Herba Hedyotidis Diffusae 5 grams, Semen Plantaginis 15 grams, Ramulus Salicis Babylonicae 7 grams, Radix Polygoni Multiflori Preparata 2 grams, Radix Saposhnikoviae 4 grams.
Wherein, the preparation method of described Chinese medicine composition is:
(1) taking each medical material of components by weight percent in described Chinese medicine composition, first time decocts the water boiling and extraction of 10-15 times that adds medical material gross weight, decocts 1.2 hours: second time adds the water of 8-12 times amount, decocts 1-1.2h, leaches medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 0.8-1.2h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.10-1.30;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 60-75%, to stand 24-48 hour, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 50-60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) to above-mentioned steps (2) obtain centrifugal after concentrated solution in add suitable amount of sucrose, essence mixing, sterilizing, fill, prepare medicinal liquid agent.
Acute toxicity test:
Take mice 60, body weight 22-25 gram, be randomly divided into 2 groups by body weight, treatment group and matched group: treatment group takes the medicinal liquid agent of the embodiment of the present invention 6 preparation, and 0.40ml/10g body weight gastric infusion, dose 0.38g/ml are pressed in fasting after 12 hours, matched group takes distilled water, three times on the one, to observation post administration 14 days, none was dead for mice, main organs no abnormality seen, also have no other substantially abnormal, within the 14th day, put to death and cut open inspection some animals, perusal main organs no abnormality seen.
Six months long term toxicity tests: weigh weekly once during administration, claim appetite every day, and without dead or moribund animals, result mice hair color is bright and clean, and behavioral activity, glandular secretion, breathing, feces character are all normal.Pathologic finding is pointed out, to various internal organs without obvious drug-induced pathological change.
Clinical reasoning:
In order to verify the effect of pharmaceutical composition of the present invention, in January, 2013 in JIUYUE ,-2014, chronic cholecystitis patient 200 example is randomly drawed in outpatient service place, random digits table is adopted to be randomly divided into treatment group and matched group, wherein treatment group 100 example, male 49 example, women 51 example, 22~65 years old age;Matched group 100 example, male 50 example, women 50 example, 21~68 years old age.2 groups of sexes, age, courses of disease etc. compare, difference there are no significant meaning (P > 0.05), have comparability.
Diagnostic criteria:
Western medicine diagnose standard: (1) continues upper right abdomen dull pain or sense of discomfort or Ban Youjianjiao district pain.(2) there are the indigestion symptoms such as nauseating, belch, pantothenic acid, abdominal distention and scorching hot, greasy food postemphasis of taking food.(3) course of disease is long, and the course of disease is through having acute attack and alleviating feature alternately.(4) there are mild tenderness or percussion pain in gallbladder area.(5) the visible gallbladder wall of B ultrasonic is crude thickens, or companion's entrant sound is abnormal, and gallbladder reduces or deforms, and maybe can have cholelithiasis.(6) the visible gallbladder of cholecystography reduces or deforms, and gallbladder contraction function is bad, or gallbladder development is thin, or visible cholelithiasis.
All possess (5), one of in (6) two, add the binomial person in the item of (1)-(4), namely diagnosable.
Chinese medical discrimination:
Liver qi stagnation type: pain in the right hypochondrium is based on distending pain, and it is indefinite to walk to alter, and pain often increases, sensation of oppression over the chest with shortness of breath, indigestion and loss of appetite lack of appetite because of feelings will, belch frequency is made, yellow fur, stringy and thready pulse.
Qi stagnation blood stasis type: hypochondriac pain, based on twinge, aches localized pain, or pain draws the shoulder back of the body, enters Night Watch very, feels sick, and belch, poor appetite, purplish tongue is dark, deep and hesitant pulse.
Liver gallbladder damp-heat type: the pain over the hypochondriac region, feeling of fullness, bitter taste, nausea and vomiting, asthenia, conjunctival congestion yellowish body, dark coloured urine dry stool, yellowish fur, wiry and frequent pulse.
Deficiecny of liver-YIN type: epigastrium dull pain, abdominal distention, indigestion and loss of appetite, shallow complexion, singultus, bitter taste, in the heart dysphoria with smothery sensation, have a dizzy spell, red tongue, few tongue, thready,weak and rapid pulse.
Exclusion standard:
(1) acute simplex cholecystitis, acute suppuration cholecystitis, acute gangrenous cholecystitis, acute obstructive suppurative cholecystitis, the concurrent general peritonitis person of perforation of gallbladder are turned out to be on inspection.
(2) age is at under-18s or over-65s;Gestation or women breast-feeding their children, allergic constitution or to this ingredient allergy sufferers.
(3) merge intentionally, cerebrovascular, liver, the serious disease such as kidney and hemopoietic system, psychotic.
Reject, come off and terminate experimental standard:
(1) find not meet the case of inclusive criteria after including in, rejecting need to be given.
(2) experimenter's compliance is poor, and serious adverse events occurs, and occurs complication or special physiological change should not continue to accept experiment, is accordingly to be regarded as the case that comes off.
Therapeutic Method:
Treatment group (of the present invention group) takes the granule of embodiment 1 preparation, and a 10mg is administered orally, three times on the one.
Matched group with XIAOYAN LIDAN PIAN (Boluo County, Guangdong Province with INAA pioneer Pharmaceutical Group Co., Ltd produces, lot number: 050820), three times on the one, one time 4, oral.Two groups all with two weeks for 1 course for the treatment of, therapeutic effect is with clinical symptoms and sign for foundation.
Criterion of therapeutical effect
Basic healing: Clinical symptom and sign disappears substantially, and imaging examination is normal;
Effective: Clinical symptom and sign disappears substantially, imaging examination is obviously improved;
Effective: Clinical symptom and sign partial disappearance, imaging examination has improvement;
Invalid: Clinical symptom and sign and imaging examination are without changing.
Efficacy result:
The group patient's effective percentage relative analysis of 1 liang of table
Group | Case | Basic healing | Effective | Effectively | Invalid | Total effective rate |
Matched group | 100 | 25 | 29 | 11 | 35 | 65% |
Treatment group | 100 | 76 | 13 | 7 | 4 | 96% |
Table 1 result shows: through statistical analysis, between two groups, total effective rate has the difference P < 0.05 of significance after statistical procedures.Illustrate that treatment group curative effect is substantially better than matched group.
Result shows: Chinese medicine composition provided by the invention is determined curative effect in treatment chronic cholecystitis, and is better than prior art.
Model case:
Case 1
Zhao, female, 51 years old, be Qingdao City Laoshan District people, goes to a doctor on March 16th, 2014.More than main suit's right Upper abdominal pain half a year, recently because, after drinking, the pain increased, and infrascapular region radiation to the right, big dry stool, Administration of roxithromycin and XIAOYAN LIDAN PIAN are invalid voluntarily for they.Look into: Fei Shi does not levy the positive, body temperature 38.1 DEG C.Yellowish fur, the matter green grass or young crops stasis of blood, stringy and rolling pulse.B ultrasonic shows, gollbladder dilation is 4.3~8.7cm about, and wall is crude.The capsule giving the embodiment of the present invention 3 is treated, and twice daily, each two, 10 days courses for the treatment of, after the course for the treatment of, all transference cures, body temperature is normal, and upper right abdomen mild tenderness adds again a course for the treatment of, and all diseases disappear, and do not reaccess so far.
Case 2
Money, female, 55 years old, Qingdao Jimo people, went to a doctor on May 1st, 2014.Chronic cholecystitis 5 years.Right rib distension time medical, dull uncomfortable, upper abdomen tenderness, there are dull pain, belch, poor appetite, yellow fur thickness is greasy, dimly red tongue, stringy pulse.Gallbladder x-ray contrast examination is reported as " chronic cholecystitis ", ultrasound diagnosis, and cyst wall thickens, and volume increases, and gallbladder wall is rough and coarse.The medicine decoction giving the embodiment of the present invention 5 is treated, and twice daily, 10 days courses for the treatment of, after 2 courses for the treatment of, symptom substantially alleviates, and checks through B ultrasonic, and gallbladder is clear-cut, smooth, and size and form is normal, continue to take 2 courses for the treatment of, recovery from illness, follow up a case by regular visits to after half a year without recurrence.
Case 3
Grandson, female, 49 years old, people from Shinan District, Qingdao City, went to a doctor on November 23rd, 2013.More than right Upper abdominal pain distension April, because causing upper right abdomen ache after flu, anger, accompany right shoulder back distending pain, tending to vomit of feeling sick, bitter taste poor appetite, suffer from abdominal pain after entering greasy food and increase the weight of.Red tongue, yellow and thin fur, deep and stringy pulse, ultrasound diagnosis: gallbladder 7.0cm × 3.9cm, wall thickness 0.5cm, obscuring in capsule, the powder giving the embodiment of the present invention 2 is treated, twice daily, each two bags, 10 days courses for the treatment of, after 2 courses for the treatment of, symptom is clearly better, and continues to take 3 courses for the treatment of, checks through B ultrasonic, gallbladder is clear-cut, smooth, size and form is normal, recovery from illness, follows up a case by regular visits to without recurrence after 1 year.
Last it is noted that above example is only in order to illustrate technical scheme, it is not intended to limit;Although the present invention being described in detail with reference to previous embodiment, it will be understood by those within the art that: the technical scheme described in foregoing embodiments still can be modified by it, or wherein portion of techniques feature is carried out equivalent replacement;And these amendments or replacement, do not make the essence of appropriate technical solution depart from the scope of various embodiments of the present invention technical scheme.
Claims (10)
1. the pharmaceutical composition treating chronic cholecystitis, it is characterised in that: the crude drug of described pharmaceutical composition is made up of Herba Lysimachiae, Cortex Magnoliae Officinalis, Fructus Gardeniae (parched), Fructus Toosendan, Fructus Piperis Longi, Flos Rosae Rugosae, Endothelium Corneum Gigeriae Galli, Caulis Bambusae In Taenia, Herba Gentianopsis Paludosae, Concha Ostreae, Herba Lythri Salicariae, Radix Seu Caulis Mucunae Sempervirentis, Radix Sanguisorbae, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), Radix Cucurbitae, Semen Coicis, Herba Violae dissectae, Folium Et Cacumen Murrayae, Fructus Lycii, Semen Cassiae, Semen Vaccariae, Rhizoma Acori Graminei, Radix Rubiae, Ramulus Cinnamomi, Pericarpium Citri Reticulatae Viride, Fructus Crataegi, Radix Glycyrrhizae, Herba Taraxaci, Herba Hedyotidis Diffusae, Semen Plantaginis, Ramulus Salicis Babylonicae, Radix Polygoni Multiflori Preparata, Radix Saposhnikoviae.
null2. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1,It is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 12-20 part,Cortex Magnoliae Officinalis 10-16 part,Fructus Lycii 3-8 part,Fructus Gardeniae (parched) 5-12 part,Fructus Piperis Longi 12-17 part,Fructus Toosendan 7-12 part,Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 4-9 part,Endothelium Corneum Gigeriae Galli 15-20 part,Caulis Bambusae In Taenia 10-15 part,Concha Ostreae 8-12 part,Herba Lythri Salicariae 2-5 part,Flos Rosae Rugosae 3-7 part,Radix Seu Caulis Mucunae Sempervirentis 11-14 part,Radix Sanguisorbae 9-15 part,Semen Vaccariae 3-6 part,Radix Cucurbitae 8-13 part,Herba Violae dissectae 3-5 part,Folium Et Cacumen Murrayae 1-3 part,Rhizoma Acori Graminei 5-10 part,Herba Gentianopsis Paludosae 5-10 part,Radix Rubiae 13-16 part,Ramulus Cinnamomi 3-10 part,Pericarpium Citri Reticulatae Viride 8-13 part,Fructus Crataegi 3-5 part,Semen Coicis 1-3 part,Radix Glycyrrhizae 5-10 part,Semen Cassiae 3-6 part,Herba Taraxaci 8-13 part,Herba Hedyotidis Diffusae 3-5 part,Semen Plantaginis 11-15 part,Ramulus Salicis Babylonicae 5-10 part,Radix Polygoni Multiflori Preparata 2-5 part,Radix Saposhnikoviae 4-9 part.
3. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 12 parts, Cortex Magnoliae Officinalis 16 parts, Fructus Lycii 3 parts, Fructus Gardeniae (parched) 12 parts, Fructus Piperis Longi 12 parts, Fructus Toosendan 10 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 9 parts, Endothelium Corneum Gigeriae Galli 15 parts, Caulis Bambusae In Taenia 15 parts, Concha Ostreae 8 parts, Herba Lythri Salicariae 5 parts, Flos Rosae Rugosae 3 parts, Radix Seu Caulis Mucunae Sempervirentis 14 parts, Radix Sanguisorbae 9 parts, Semen Vaccariae 6 parts, Radix Cucurbitae 8 parts, Herba Violae dissectae 5 parts, Folium Et Cacumen Murrayae 1 part, Rhizoma Acori Graminei 10 parts, Herba Gentianopsis Paludosae 5 parts, 16 parts of Radix Rubiae, Ramulus Cinnamomi 10 parts, 8 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 parts, Semen Coicis 1 part, 10 parts of Radix Glycyrrhizae, Semen Cassiae 6 parts, Herba Taraxaci 8 parts, Herba Hedyotidis Diffusae 3 parts, Semen Plantaginis 15 parts, Ramulus Salicis Babylonicae 5 parts, Radix Polygoni Multiflori Preparata 3 parts, Radix Saposhnikoviae 5 parts.
4. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 20 parts, Cortex Magnoliae Officinalis 10 parts, Fructus Lycii 8 parts, Fructus Gardeniae (parched) 5 parts, Fructus Piperis Longi 17 parts, Fructus Toosendan 12 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 4 parts, Endothelium Corneum Gigeriae Galli 20 parts, Caulis Bambusae In Taenia 10 parts, Concha Ostreae 12 parts, Herba Lythri Salicariae 2 parts, Flos Rosae Rugosae 7 parts, Radix Seu Caulis Mucunae Sempervirentis 11 parts, Radix Sanguisorbae 15 parts, Semen Vaccariae 3 parts, Radix Cucurbitae 13 parts, Herba Violae dissectae 3 parts, Folium Et Cacumen Murrayae 3 parts, Rhizoma Acori Graminei 5 parts, Herba Gentianopsis Paludosae 10 parts, 13 parts of Radix Rubiae, Ramulus Cinnamomi 3 parts, 13 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 3 parts, Semen Coicis 3 parts, 5 parts of Radix Glycyrrhizae, Semen Cassiae 4 parts, Herba Taraxaci 10 parts, Herba Hedyotidis Diffusae 4 parts, Semen Plantaginis 13 parts, Ramulus Salicis Babylonicae 6 parts, Radix Polygoni Multiflori Preparata 4 parts, Radix Saposhnikoviae 8 parts.
5. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 13 parts, Cortex Magnoliae Officinalis 11 parts, Fructus Lycii 4 parts, Fructus Gardeniae (parched) 6 parts, Fructus Piperis Longi 13 parts, Fructus Toosendan 7 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 5 parts, Endothelium Corneum Gigeriae Galli 18 parts, Caulis Bambusae In Taenia 11 parts, Concha Ostreae 9 parts, Herba Lythri Salicariae 4 parts, Flos Rosae Rugosae 6 parts, Radix Seu Caulis Mucunae Sempervirentis 12 parts, Radix Sanguisorbae 13 parts, Semen Vaccariae 4 parts, Radix Cucurbitae 9 parts, Herba Violae dissectae 4 parts, Folium Et Cacumen Murrayae 2 parts, Rhizoma Acori Graminei 6 parts, Herba Gentianopsis Paludosae 6 parts, 14 parts of Radix Rubiae, Ramulus Cinnamomi 5 parts, 10 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 4 parts, Semen Coicis 2 parts, 6 parts of Radix Glycyrrhizae, Semen Cassiae 5 parts, Herba Taraxaci 12 parts, Herba Hedyotidis Diffusae 3 parts, Semen Plantaginis 12 parts, Ramulus Salicis Babylonicae 9 parts, Radix Polygoni Multiflori Preparata 4 parts, Radix Saposhnikoviae 7 parts.
6. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 17 parts, Cortex Magnoliae Officinalis 15 parts, Fructus Lycii 7 parts, Fructus Gardeniae (parched) 11 parts, Fructus Piperis Longi 16 parts, Fructus Toosendan 8 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 8 parts, Endothelium Corneum Gigeriae Galli 16 parts, Caulis Bambusae In Taenia 14 parts, Concha Ostreae 11 parts, Herba Lythri Salicariae 3 parts, Flos Rosae Rugosae 5 parts, Radix Seu Caulis Mucunae Sempervirentis 13 parts, Radix Sanguisorbae 14 parts, Semen Vaccariae 5 parts, Radix Cucurbitae 12 parts, Herba Violae dissectae 3 parts, Folium Et Cacumen Murrayae 1 part, Rhizoma Acori Graminei 10 parts, Herba Gentianopsis Paludosae 9 parts, 13 parts of Radix Rubiae, Ramulus Cinnamomi 7 parts, 11 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 3 parts, Semen Coicis 1 part, 10 parts of Radix Glycyrrhizae, Semen Cassiae 4 parts, Herba Taraxaci 11 parts, Herba Hedyotidis Diffusae 4 parts, Semen Plantaginis 14 parts, Ramulus Salicis Babylonicae 8 parts, Radix Polygoni Multiflori Preparata 3 parts, Radix Saposhnikoviae 6 parts.
7. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 15 parts, Cortex Magnoliae Officinalis 12 parts, Fructus Lycii 5 parts, Fructus Gardeniae (parched) 9 parts, Fructus Piperis Longi 15 parts, Fructus Toosendan 9 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 7 parts, Endothelium Corneum Gigeriae Galli 19 parts, Caulis Bambusae In Taenia 13 parts, Concha Ostreae 10 parts, Herba Lythri Salicariae 4 parts, Flos Rosae Rugosae 4 parts, Radix Seu Caulis Mucunae Sempervirentis 11 parts, Radix Sanguisorbae 11 parts, Semen Vaccariae 5 parts, Radix Cucurbitae 10 parts, Herba Violae dissectae 5 parts, Folium Et Cacumen Murrayae 3 parts, Rhizoma Acori Graminei 8 parts, Herba Gentianopsis Paludosae 8 parts, 14 parts of Radix Rubiae, Ramulus Cinnamomi 9 parts, 12 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 parts, Semen Coicis 3 parts, 8 parts of Radix Glycyrrhizae, Semen Cassiae 6 parts, Herba Taraxaci 9 parts, Herba Hedyotidis Diffusae 5 parts, Semen Plantaginis 12 parts, Ramulus Salicis Babylonicae 7 parts, Radix Polygoni Multiflori Preparata 5 parts, Radix Saposhnikoviae 9 parts.
8. the pharmaceutical composition for the treatment of chronic cholecystitis according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: Herba Lysimachiae 19 parts, Cortex Magnoliae Officinalis 14 parts, Fructus Lycii 6 parts, Fructus Gardeniae (parched) 7 parts, Fructus Piperis Longi 14 parts, Fructus Toosendan 9 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 6 parts, Endothelium Corneum Gigeriae Galli 17 parts, Caulis Bambusae In Taenia 13 parts, Concha Ostreae 10 parts, Herba Lythri Salicariae 4 parts, Flos Rosae Rugosae 4 parts, Radix Seu Caulis Mucunae Sempervirentis 11 parts, Radix Sanguisorbae 11 parts, Semen Vaccariae 5 parts, Radix Cucurbitae 10 parts, Herba Violae dissectae 5 parts, Folium Et Cacumen Murrayae 3 parts, Rhizoma Acori Graminei 8 parts, Herba Gentianopsis Paludosae 8 parts, 14 parts of Radix Rubiae, Ramulus Cinnamomi 4 parts, 9 parts of Pericarpium Citri Reticulatae Viride, Fructus Crataegi 5 parts, Semen Coicis 3 parts, 8 parts of Radix Glycyrrhizae, Semen Cassiae 3 parts, Herba Taraxaci 8 parts, Herba Hedyotidis Diffusae 5 parts, Semen Plantaginis 15 parts, Ramulus Salicis Babylonicae 7 parts, Radix Polygoni Multiflori Preparata 2 parts, Radix Saposhnikoviae 4 parts.
9. the preparation method of the pharmaceutical composition of the arbitrary described treatment chronic cholecystitis of claim 3-8, it is characterised in that described preparation method comprises the steps of:
(1) each medical material of components by weight percent in the arbitrary described pharmaceutical composition of claim 3-8 is taken, first time decocts the water boiling and extraction of 10-15 times that adds medical material gross weight, decoct 1-2 hour: second time adds the water of 8-12 times amount, decoct 1-1.2h, leach medicinal liquid stand-by;Third time adds the water of 8-12 times amount, decocts 0.8-1.2h, leaches medicinal liquid stand-by;Merging three decocting liquids, filter, collect filtrate, being concentrated into relative density when 50-60 DEG C is the clear paste of 1.10-1.30;
(2) clear paste that step (1) prepares is placed to room temperature, add ethanol and make, containing amount of alcohol to percentage by weight 60-75%, to stand 24-48 hour, take supernatant;Supernatant reclaims ethanol, and being evaporated to relative density when 50-60 DEG C is the clear paste of 1.20-1.30, centrifugal under the rotating speed of 3000r/min subsequently;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(3) dry extract that step (2) prepares is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, granule can be prepared;Or the dry extract that step (2) prepares be dry, pulverize, make powder;Or dry extract step (2) prepared is pulverized, add appropriate micropowder silica gel, α-galactose mixing, with ethanol for wetting agent, granulate, dry, granulate, encapsulated, prepare capsule;Or dry extract step (2) prepared is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, tabletting, prepare tablet;Or to above-mentioned steps (2) obtain centrifugal after concentrated solution in add suitable amount of sucrose, essence mixing, sterilizing, fill, prepare medicinal liquid agent.
10. the application in treatment chronic cholecystitis medicine of the pharmaceutical composition of the treatment chronic cholecystitis as described in as arbitrary in claim 1-8.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610124428.6A CN105727069A (en) | 2016-03-04 | 2016-03-04 | Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610124428.6A CN105727069A (en) | 2016-03-04 | 2016-03-04 | Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105727069A true CN105727069A (en) | 2016-07-06 |
Family
ID=56250031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610124428.6A Pending CN105727069A (en) | 2016-03-04 | 2016-03-04 | Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105727069A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115634245A (en) * | 2022-10-09 | 2023-01-24 | 西南民族大学 | Veterinary drug composition, decoction thereof, preparation method and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102872359A (en) * | 2012-09-27 | 2013-01-16 | 孟宪兰 | Traditional Chinese medicine composition for treating chronic cholecystitis |
CN105213885A (en) * | 2015-10-19 | 2016-01-06 | 青岛市中心医院 | A kind of pharmaceutical composition and application thereof for the treatment of acute pancreatitis |
-
2016
- 2016-03-04 CN CN201610124428.6A patent/CN105727069A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102872359A (en) * | 2012-09-27 | 2013-01-16 | 孟宪兰 | Traditional Chinese medicine composition for treating chronic cholecystitis |
CN105213885A (en) * | 2015-10-19 | 2016-01-06 | 青岛市中心医院 | A kind of pharmaceutical composition and application thereof for the treatment of acute pancreatitis |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115634245A (en) * | 2022-10-09 | 2023-01-24 | 西南民族大学 | Veterinary drug composition, decoction thereof, preparation method and application |
CN115634245B (en) * | 2022-10-09 | 2023-09-26 | 西南民族大学 | Veterinary medicine composition and decoction for preventing and treating liver injury of livestock and poultry and application of veterinary medicine composition and decoction |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN103751716B (en) | A kind of pharmaceutical composition for the treatment of renal calculus and cholelithiasis | |
CN106110043A (en) | One treats prostatitic Chinese medicine composition and preparation method thereof | |
CN104815192A (en) | Pharmaceutical composition for treating hypertension and application of pharmaceutical composition | |
CN106994141B (en) | Traditional Chinese medicine composition for treating constipation and preparation method thereof | |
CN104940718A (en) | Pharmaceutical composition for treatment of chronic cholecystitis and preparation method thereof | |
CN101884779A (en) | Siberian solomonseal rhizome composition for intervening sub-health state and preparation method thereof | |
CN104147574A (en) | Heat-clearing and exterior-releasing traditional Chinese medicine composition for treating cold and fever and preparation method thereof | |
CN110151851A (en) | Compound and its application based on a kind of Radix Glycyrrhizae medicine pair by honeysuckle | |
CN104771578A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN104784549A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN105727069A (en) | Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition | |
CN103169863B (en) | Medicament for treating constipation and preparation method thereof | |
CN105435131A (en) | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof | |
CN104857414A (en) | Medicine composite for treating chronic simple rhinitis | |
CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
CN104435957A (en) | Preparation method of Chinese medicinal preparation for treating lung abscess | |
CN102631648A (en) | Chinese patent medicine for treating acute urticaria | |
CN107137689A (en) | A kind of Chinese medicine composition for treating menopausal syndrome | |
CN107737292B (en) | Traditional Chinese medicine preparation for treating senile nocturia and preparation method thereof | |
CN105998979A (en) | Traditional Chinese medicine composition for treating lung-and-kidney-yin-deficiency-type chronic pharyngitis and method | |
CN106110156A (en) | A kind of cream side for chronic obstructive pulmonary disease, preparation method and its usage | |
CN104740403A (en) | Medicine for treating blood-insufficiency and yin-deficiency recurrent oral ulceration and preparation method thereof | |
CN105125693A (en) | Traditional Chinese medicine composition for treating acute gastritis and preparing method thereof | |
CN105267815A (en) | Spray for treating infant lung-kidney-deficiency type asthma and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160706 |
|
RJ01 | Rejection of invention patent application after publication |